|
AARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.112180E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.354500E-04 |
| Normal-vs-Stage2 |
6.450800E-01 |
| Normal-vs-Stage3 |
3.681600E-02 |
| Normal-vs-Stage4 |
8.690200E-01 |
| Stage1-vs-Stage2 |
2.775400E-01 |
| Stage1-vs-Stage3 |
2.415500E-03 |
| Stage1-vs-Stage4 |
3.623400E-01 |
| Stage2-vs-Stage3 |
4.302400E-02 |
| Stage2-vs-Stage4 |
6.816600E-01 |
| Stage3-vs-Stage4 |
2.959400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.691410E-01 |
| Normal-vs-AfricanAmerican |
1.004570E-01 |
| Normal-vs-Asian |
3.393600E-01 |
| Caucasian-vs-AfricanAmerican |
5.607000E-01 |
| Caucasian-vs-Asian |
2.828800E-01 |
| AfricanAmerican-vs-Asian |
2.501800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.405900E-04 |
| Normal-vs-Female |
1.181230E-01 |
| Male-vs-Female |
2.743400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.153000E-01 |
| Normal-vs-Extreme_Weight |
7.830300E-04 |
| Normal-vs-Obese |
6.893600E-01 |
| Normal-vs-Extreme_Obese |
3.322100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.528600E-01 |
| Normal_Weight-vs-Obese |
4.640200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.132000E-01 |
| Extreme_Weight-vs-Obese |
4.734200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.086200E-01 |
| Obese-vs-Extreme_Obese |
3.721600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.227000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.808000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.534120E-02 |
| Normal-vs-Age(81-100Yrs) |
1.254410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.698300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.053500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.797900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.764200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.010600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.656400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.81880000019675E-07 |
| Normal-VS-Type2 PRCC |
3.108400E-01 |
| Normal-VS-KIRP CIMP |
1.000970E-01 |
| Normal-VS-Unclassified PRCC |
3.615000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.036800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.406200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.143900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.275030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.721200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.301180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.670200E-01 |
| Normal-vs-N1 |
1.231030E-01 |
| Normal-vs-N2 |
7.924400E-01 |
| N0-vs-N1 |
7.598300E-02 |
| N0-vs-N2 |
5.614400E-01 |
| N1-vs-N2 |
6.460200E-01 |
|
|
